Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pulse Biosciences

17.91
-1.3600-7.06%
Post-market: 17.910.00000.00%17:40 EDT
Volume:189.70K
Turnover:3.46M
Market Cap:1.20B
PE:-19.52
High:19.45
Open:19.32
Low:17.55
Close:19.27
Loading ...

Company Profile

Company Name:
Pulse Biosciences
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
75
Office Location:
601 Brickell Key Drive,Suite 1080,Miami,Florida,United States
Zip Code:
33131
Fax:
- -
Introduction:
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.

Directors

Name
Position
Darrin R. Uecker
President and Chief Executive Officer and Director
Robert M. Levande
Chairman of the Board
Maky Zanganeh
Director
Mitchell E. Levinson
Director
Robert J. Greenberg
Director
Thierry B. Thaure
Director

Shareholders

Name
Position
Darrin R. Uecker
President and Chief Executive Officer and Director
Brian B. Dow
Chief Financial Officer, Senior Vice President, Treasurer and Secretary